ORKA
Oruka Therapeutics Inc.
Latest News for ORKA
In a report released today, Michael Yee from UBS maintained a Buy rating on Oruka Therapeutics, with a price target of $75.00. According to TipRank......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA)......
Oruka Therapeutics, Inc. ($ORKA) announced an update on their ongoing clinical study. The study, titled “Phase 1, First-in-human, Double-Blind, Pla......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Citius Oncology (CTOR – Research Report) and Oruka T......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Denali Therapeutics (DNLI – Research Report) and Oru......
In a report released yesterday, Yatin Suneja from Guggenheim reiterated a Buy rating on Oruka Therapeutics, with a price target of $60.00. The comp......
Jefferies analyst Roger Song maintained a Buy rating on Oruka Therapeutics today and set a price target of $45.00. Song covers the Healthcare secto......
News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORKA | $61.76 | +1.9% | 1.21M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |